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Abstract
The benzophenothiazinium dye EtNBS has previously been tested as a photosensitizer to mediate
photodynamic therapy (PDT). It has been employed to kill cancer cells and microbial cells in vitro
and to treat tumors and infections in vivo. We synthesized a panel of derivatives substituted at the
1-position of the benzene ring with electron donating or electron withdrawing groups (amino,
acetamido and nitro) and tested their production of reactive oxygen species (ROS) and light-
mediated killing of two species of Gram-positive and two species of Gram-negative bacteria. All
three compounds showed lower fluorescence, lower yield of ROS and less microbial killing than
parent EtNBS, while the order of activity (nitro>amino>acetamido) showed that an electron
withdrawing substituent was better than electron donating. To test the hypothesis that 1-
substitution distorts the planar structure of the conjugated rings we compared two compounds
substituted with N-ethylpropylsulfonamido either at the 1-position or at the 4-position. The 4-
isomer was significantly more photoactive than the 1-isomer. We also prepared an EtNBS
derivative with a guanidinium group attached to the 5-amino group. This compound had high
activity against Gram-negative bacteria due to the extra positive charge. Cellular uptake of the
compounds by the four bacterial species was also measured and broadly correlated with activity.
These results provided three separate pieces of structure-activity relationship data for
antimicrobial photosensitizers based on the EtNBS backbone
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INTRODUCTION
One of the major problems in the management of infectious disease today is the inexorable
worldwide increase in antibiotic resistance occurring in different bacterial species [1]. This
problem has led to increasing interest in the discovery of new antimicrobial treatments that
will be equally effective against multi-drug resistant strains. Since its discovery over a
century ago, photodynamic therapy (PDT) is now emerging as a new clinical approach to
infections [2] as well as cancer [3]. PDT is already approved as an effective method for
treatment of solid tumors in humans [3] as well as age-related macular degeneration and
other indications in ophthalmology [4]. The application of PDT as an antimicrobial
treatment involves the topic (or less likely systemic) application of a non-toxic dye called a
photosensitizer (PS), followed by delivery of light of an appropriate wavelength in the
presence of ambient molecular oxygen. The absorption of a photon is able to excite the PS to
its excited singlet state that can convert to a long-lived triplet state that can then react with
oxygen, producing reactive oxygen species (ROS), or with other molecules producing
radicals through two complementary pathways, Type I (electron transfer) and Type II
(energy transfer) processes. ROS (singlet oxygen and hydroxyl radicals) can react with
many cellular components. These reactive radical species are able to oxidize biomolecules
such as amino acids, nucleotides and unsaturated lipids inducing cell death [5]. The
spectrum of microbial targets of PDT is very broad including viruses, all classes of bacteria,
fungi and parasites. It was observed that the activity of PDT is different towards Gram-
positive and Gram-negative bacteria and this is mainly due to the structural differences in
the cellular architecture primarily of the bacterial cell wall [6]. Gram-positive bacteria and
fungi are more susceptible to PDT because their cytoplasmic membrane is surrounded by a
relatively porous layer of peptidoglycan and lipoteichoic acid, or beta-glucan and chitin,
respectively; these structures allow easier penetration of PS [7]. Many studies have been
carried out to improve antimicrobial PDT against Gram-negative species [8]. Clinically
antimicrobial PDT has been widely applied in dentistry where it is used to kill
periodontopathogenic bacteria in the dental pocket to treat periodontitis, and to sterilize root
canals in endodontic therapy [9, 10].
An important factor to increase and improve the efficacy of PDT is to optimize the structure
of the PS. The Nile blue derivative, 5-(ethylamino)-9-diethylamino-
benzo[a]phenothiazinium chloride (EtNBS) in combination with red light has been reported
to be able to mediate killing of cancer cells [11] and 3D cancer models [12, 13] in vitro, and
to treat tumors in vivo [14-16]. Furthermore its positive charge suggested it could mediate
photodestruction of a wide range of microorganisms. Foley et al. [17] evaluated the
antimicrobial PDT efficacies of EtNBS and two chalcogen derivatives (EtNBA, oxygen, and
EtNBSe, selenium) against the Gram-positive bacterium Enterococcus faecalis, the Gram-
negative bacterium Escherichia coli, and the yeast Candida albicans. In another study [18]
the PDT activity of EtNBS and EtNBSe against Mycobacterium bovis BCG was evaluated in
both in vitro and in vivo models. Later, Verma et al. [19] investigated the antimicrobial
photodynamic activity of two EtNBS derivatives containing functional group modifications
to enhance specificity and these compounds were tested on two representative Gram-
positive and Gram-negative bacterial strains. EtNBS and EtNBSe have also been used to
mediate PDT destruction of Leishmaniasis parasites in vitro [20].
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EtNBS derivative compounds to date have largely been created through modifications to the
amine side groups or through replacement of the central ring chalcogen. These modifications
are functionally orthogonal, with the heavier chalcogen (Se) derivative leading to increased
intersystem crossing and subsequent singlet oxygen production [17]. Side chain
modifications, on the other hand, enable the tuning of properties such as molecular
hydrophobicity and charge. Side chain derivatives were found to alter photosensitizer
uptake, localization, and ultimately PDT efficacy both in the treatment of microorganisms
and cancer [21].
Nile blue derivatives such as EtNBS have unique properties that make them good
photosensitizers for anti-microbial therapy. Though EtNBS is a lipophilic compound, it also
has a single charge delocalized throughout its ring system making the molecule readily
water soluble. Containing only a single sulfur heteroatom in the ring, EtNBS actually has a
relatively low singlet oxygen quantum yield of 3% [19]. Nevertheless, EtNBS has been
observed to be a potent photosensitizer. Recent studies investigating EtNBS and structural
derivatives in vitro have found that the molecule can act via both Type I and Type II
photochemical pathways. This consideration allows EtNBS to operate over a wide range of
oxygen tensions, even in severely hypoxic environments [13, 21]. This property could be of
significant benefit, especially in the treatment of complex infections and biofilms where
oxygen is not always present in high concentrations.
The high PDT activity of EtNBS and its derivatives, and the broad-spectrum of microbial
targets observed in the previous reports taken together support more studies on new
derivatives to better understand the structural features needed for improved efficacy of PDT.
For this reason, in the present study we aimed to evaluate the effect of EtNBS and a panel of
novel derivatives on two Gram-positive bacterial strains Staphylococcus aureus and E.
faecalis and two Gram-negative strains, E. coli and Acinetobacter baumannii. Initially we
tested three derivatives with electron-withdrawing (nitro, EtNBS-N) or electron-donating
(amino, EtNBS-A and acetamido, EtNBS-Ac) groups prepared by substitution at the 1-
position of the benzene ring. We then tested the hypothesis that 1-substitution distorts the
planar structure of the conjugated rings by comparing two compounds substituted with N-
ethylpropylsulfonamido either at the 1-position (EtNBS-So), or at the 4-position (EtNBS-
Sp). Finally as small cationic molecules such as EtNBS have been found potent against
microorganisms, the arginine side-chain (EtNBS-G) derivative was included in this study to
examine the role of increased charge on photosensitizer uptake and activity. All the
structures are shown in Table 1.
Materials and methods
Synthesis of compounds
5-(ethylamino)-9-diethylaminobenzo[a]phenothiazinium chloride (EtNBS) and Bunte Salt
(sodium 2-amino-5-diethylaminophenylthiosulfuric acid) were prepared according to
previously published procedures [22].
General method for synthesis of the EtNBS derivatives—A refluxing mixture of
derivatized naphthylamine (1.0 mmol) and Bunte salt (138 mg, 0.5 mmol) in 25 mL of
methanol was charged with silver carbonate (303 mg, 1.1 mmol), and allowed to stir for
about 30 min. The deep blue reaction mixture was then filtered through a pad of celite and
concentrated to near-dryness with the aid of a rotary evaporator. The resulting solid was
portioned between 25 mL dichloromethane and 25 mL saturated sodium carbonate solution.
The organic layer was separated, acidified with ~0.25 mL conc. HCl and allowed to dry
overnight in a fume hood. The crude product was purified by silica-gel chromatography
using 5 - 10% methanol in dichloromethane as the mobile phase.
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Derivatives EtNBS-A, EtNBS-Ac and EtNBS-G were further purified in small batches by
reversed-phase high-performance liquid chromatography.
N-(9-(diethylamino)-1-nitro-5H-benzo[a]phenothiazin-5-ylidene)ethanaminium
(EtNBS-N): This compound was synthesized starting with N-ethyl-5-nitronaphthalen-1-
amine. 1H NMR (DMSO-d6) δ 9.93 (m, 1H), 8.82 (d, J = 8.7 Hz, 1H), 8.30 (d, J = 7.8 Hz,
1H), 8.07 (t, J = 7.8 Hz, 1H), 7.7-7.5 (m, 4H), 3.77 (m, 6H), 1.42 (t, J = 7.2 Hz, 3H), 1.29 (t,
J = 7.2 Hz, 6H). MALDI-MS calculated for C22H23N4O2S+: 407.1; found 407.0. HPLC
retention time = 22.3 min, conditions: C-18 reversed-phase column (4.6 mm × 250 mm),
eluting with CH3CN in water (20% to 100% in 25 min) with a flow rate of 1.0 mL/min.
N-(1-amino-9-(diethylamino)-5H-benzo[a]phenothiazin-5-ylidene)ethanaminium
(EtNBS-A): This compound was synthesized starting with tert-butyl (5-
(ethylamino)naphthalen-1-yl)carbamate. 1H NMR (DMSO-d6) δ 9.92 (br, 1H), 8.5(br, 2H),
8.13 (br, m, 1H), 7.75 (m, 1H), 7.7-7.5 (m, 2H), 7.4-7.2 (m, 3H), 3.83 (q, J = 7.2 Hz, 2H),
3.67 (q, J = 6.9 Hz, 4H), 1.39 (t, J = 7.2 Hz, 3H), 1.26 (t, J = 6.9 Hz, 6H). MALDI-MS
calculated for C22H25N4S+: 377.17; found 337. HPLC retention time = 23.7 min,
conditions: C-18 reversed-phase column (4.6 mm × 250 mm), eluting with CH3CN in water
(20% to 100% in 25 min) with a flow rate of 1.0 mL/min.
N-(1-acetamido-9-(diethylamino)-5H-benzo[a]phenothiazin-5-ylidene)-ethanaminium
(EtNBS-Ac): This compound was synthesized starting with N-(5-(ethylamino)naphthalen-1-
yl)acetamide. 1H NMR (DMSO-d6) δ 13.88 (s, 1H), 10.05 (t, br, J = 6 Hz, 1H), 9.13(d, J =
7.8 Hz, 1H), 8.27 (d, J = 9 Hz, 1H), 7.99 (d, J = 9 Hz, 1H), 7.91 (t, J = 8.1 Hz, 1H), 7.71 (s,
1H), 7.50 (m, 2H), 3.83 (m, J = 7.2 Hz, 2H), 3.73 (m, J = 6.9 Hz, 4H), 2.44 (s, 3H), 1.42 (t,
J = 7.2 Hz, 3H), 1.29 (t, J = 6.9 Hz, 6H). MALDI-MS calculated for C24H27N4OS+: 419.1;
found 419.0. HPLC retention time = 23.3 min, conditions: C-18 reversed-phase column (4.6
mm × 250 mm), eluting with CH3CN in water (20% to 100% in 25 min) with flow rate of
1.0 mL/min.
N-(9-(diethylamino)-1-(N-ethylpropylsulfonamido)-5H-benzo[a]phenothiazin-5-
ylidene)ethanaminium (EtNBS-So): This compound was synthesized starting with N-
ethyl-N-(5-(ethylamino)naphthalen-1-yl)propane-1-sulfonamide. 1H NMR (DMSO-d6) δ
9.73 (m, 1H), 8.55 (d, 1H, J = 7.8 Hz), 8.21 (d, 1H, J = 9 Hz), 7.91 (m, 2H), 7.56 (s, 1H),
7.48 (m, 2H), 4.07 (m, 1H), 3.75 – 3.64 (m, 6H), 3.56 – 3.48 (m, 1H), 3.22 – 3.15 (m, 2H),
1.71 (m, 2H), 1.34 (t, 3H, J = 7.2 Hz), 1.26 (t, J = 6.9 Hz, 6H), 1.07 (t, J = 7.2 Hz, 3H), 0.95
(t, 3H, J = 7.2 Hz). MALDI-MS calculated for C27H35N4S2O2 +: 511.21; found 511. HPLC
retention time = 24 min, conditions: C-18 reversed-phase column (4.6 mm × 250 mm);
eluting solvent: CH3CN in water (20% to 100% in 25 min) with flow rate of 1.0 mL/min
N-(9-(diethylamino)-4-(N-ethylpropylsulfonamido)-5H-benzo[a]phenothiazin-5-
ylidene)ethanaminium (EtNBS-Sp): This compound was synthesized starting with N-
ethyl-N-(8-(ethylamino)naphthalen-1-yl)propane-1-sulfonamide. 1H NMR (DMSO-d6) δ
10.11 (m, 1H), 9.2 (d, 1H, J = 8.1 Hz), 8.1 – 8.05 (m, 2H), 8.0 (t, 1H, J = 8.1 Hz), 7.51 (m,
2H), 7.48 (dd, 1H, J = 9.5 Hz and J = 3.3 Hz), 4.04 (m, 2H), 3.9 – 3.6 (m, 8H), 1.73 (m,
2H), 1.39 (t, 3H, J = 7.2 Hz), 1.23 (t, J = 6.9 Hz, 6H), 1.1 (t, J = 7.2 Hz, 3H), 1.0 (t, 3H, J =
7.2 Hz). MALDI-MS calculated for C27H35N4S2O2 +: 511.21; found 511. HPLC retention
time = 25.5 min, conditions: C-18 reversed-phase column (4.6 mm × 250 mm); eluting
solvent: CH3CN in water (20% to 100% in 25 min) with flow rate of 1.0 mL/min.
2-((amino(iminio)methyl)amino)-N-(9-(diethylamino)-5H-benzo[a]phenothiazin-5-
ylidene)ethanaminium (EtNBS-G): This compound was synthesized starting with N,N’-di-
Vecchio et al. Page 4
Eur J Med Chem. Author manuscript; available in PMC 2015 March 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
boc-N”-(2-(naphthalen-1-ylamino)ethyl)guanidine [23]. 1H NMR (MeOD): δ 9.12 (d, 1H, J
= 1.1 Hz), 8.33 (d, 1H, J = 8.0 Hz), 8.07 (d, 1H, J = 9.5 Hz), 7.92 (t, 1H, J = 7.0 Hz), 7.83
(m, 1H), 7.48 (dd, 1H, J = 2.7 Hz and J = 9.5 Hz), 7.38 (s, 1H), 7.32 (d, 1H, J = 2.7 Hz),
3.91 (t, J = 5.6 Hz, 2H), 3.73 (q, J = 7.1 Hz, 4H), 3.7 – 3.65 (m, 2H), 3.62 (br, 4H), 1.32 (t, J
= 7.1 Hz, 6H). MALDI-MS calculated for C23H27N6S+: 419.20; found 419. HPLC retention
time = 20.0 min, conditions: C-18 reversed-phase column (4.6 mm × 250 mm), eluting with
CH3CN in water (20% to 100% in 25 min) with flow rate of 1.0 mL/min.
EtNBS and derivatives were dissolved in N,N-dimethylacetamide (DMA), final
concentration 5 mM, and stored in the dark at 4 °C.
Spectra
The absorbance and fluorescence emission spectra of all compounds (EtNBS and EtNBS
derivatives at 10 μM in both water and methanol) were measured. Fluorescence spectra were
measured using the appropriate excitation maximum wavelength for each separate
compound.
The calculated Log P values and TPSA (topological polar surface area [24]) values were
obtained using ChemBioDraw Ultra (version 12.0.3.1216, Cambridgesoft, Cambridge, MA).
The measured Log P values were experimentally determined for all compounds (EtNBS and
EtNBS derivatives). A mixture of 1.5 mL of octanol, 1.5 mL of PBS and 100 μM of EtNBS
or derivatives in a 10-mL vial was stirred at room temperature overnight. The mixture was
allowed to stand for 30 min to allow separation of the phases. The absorbance of 1 ml
aliquot of each phase, not diluted and diluted 1:2 and 1:10 was measured at specific peak of
absorbance obtained from absorption spectra. The ratio of the two phases (octanol/PBS) was
calculated; the log(10) of the measured ratios are hereafter denoted “meas logP values”.
Light Source
Bacterial suspensions were irradiated with 635nm ± 15 nm light delivered by a non-coherent
light source fitted with a band-pass filter and a light guide (LumaCare, Newport Beach, CA).
Although the absorption spectra of the compounds had differences between them it was
considered that 635-nm was the best single wavelength to excite them all. Fluence rates
were routinely measured using a power meter (Coherent, Portland, OR).
ROS generation assay
Experiments on cell-free solutions were carried out in 96-well plates. All compounds were
diluted in PBS to 5 μM final concentration per well, and 3-(4-hydroxyphenyl)fluorescein
(HPF) or singlet oxygen sensor green (SOSG) (Molecular Probes Invitrogen) was added to
each well (final concentration 5 μM). Each experimental group contained 4 wells and all of
them were illuminated simultaneously and 635-nm light was delivered in sequential doses of
1 J/cm2 to 15 J/cm2. The fluorescence signals were acquired by a microplate
spectrophotometer (Spectra Max M5, Molecular Devices) in the “slow kinetic” mode. When
HPF was employed, fluorescence emission at 515 nm was measured upon excitation at 490
nm using 2 nm monochromator bandpass for both excitation and emission. With SOSG, the
corresponding values were 505 and 525 nm, respectively.
Bacterial culture
Four bacterial strains were studied. Staphylococcus aureus 8325-4, and Enterococcus
faecalis (ATCC29212) as Gram (+) bacteria; Acinetobacter baumanii (ATCC 51393), and
Escherichia coli (ATCC53868) as Gram (−) bacteria. Bacteria were grown in brain-heart
infusion (BHI) broth (Fischer Scientific), at 37°C overnight, in an orbital shaking incubator.
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Th e day after the incubation an aliquot was refreshed in new BHI medium and incubated at
37°C for 3 h. The optical density at 600 nm was measured by a spectrophotometer (Thermo
Scientific, Waltham, MA), OD600 = 0.5, corresponding to 108 colony forming units (CFU)/
ml. The suspensions were centrifuged (5 min, 3500 rpm) and the pellet was suspended in
sterile PBS at concentration 108CFU/ml for phototoxicity experiments
Photodynamic inactivation of bacteria in vitro
Bacterial suspensions at concentration 108 CFU/mL were incubated in PBS in the dark at
room for 10 min with different concentrations of EtNBS and all derivatives in the range
0.1-100 μM (obtained by diluting 5 mM DMA stock solutions of each compound). After the
incubation with PS, 100 μL aliquots of the cell suspensions were placed in 96 well plates.
The wells were illuminated from the top of the plates by use of red light (635-nm) at a
fluence 10J/cm2 delivered at an irradiance of 50 mW/cm2. To determine the CFU, aliquots
taken after illumination were serially diluted, streaked on nutrient agar according to the
method of Jett et al [25], and incubated in the dark for 18 h at 37°C. Experiments were
carried out in triplicate for each condition. Controls using the same amount of organic
solvent (2% DMA), in the presence of each PS and without light, and with light alone, were
performed for all experimental conditions, obtaining less than 1-log10 reduction in bacterial
viability in all cases.
Uptake of compounds by bacterial cells
Suspensions of microbial cells (108/ml) were incubated in the dark at room temperature for
10 minutes with concentrations in the range 0.05-10 μM of all compounds. The cell
suspensions were centrifuged, the supernatant was aspirated and bacteria were washed twice
with PBS and centrifuged. The cell pellet was dissolved in 100 μl of RIPA solution
(PerkinElmer Inc., Waltham, MA) at room temperature for 30 minutes to give a
homogeneous solution. The fluorescence of the cell lysates was measured using appropriate
excitation and emission wavelength for each compound with a fluorescence plate reader
(Molecular Devices, Sunnyvale CA). Following the fluorescence measurement, the total
protein concentration was determined with a bicinchoninic acid protein assay kit (Sigma)
using bovine serum albumin to prepare protein calibration curves. Individual fluorescence
calibration curves were prepared for known concentrations of each of all compounds.
Results
Structures
The structures of the seven different EtNBS derivatives are shown in Table 1 together with
the calculated and measured Log P and TPSA values. The correlation between measured and
calculated Log P values is shown in supplementary Fig S4 with a R value of 0.82 considered
to be a good correlation. The order of log P values was EtNBS-G < EtNBS-A < EtNBS-Ac
< EtNBS-N < EtNBS < EtNBS-So = EtNBS-Sp. The order of TPSA values was EtNBS <
EtNBS-A < EtNBSAc < EtNBS-So = Et NBS-Sp < EtNBS-N < EtNBS-G.
Spectroscopy
The absorption spectra of the seven compounds are shown in Figures 1A (MeOH) and
Figure 1B (water). The spectra in MeOH had much sharper peaks than they did in water and
the overall intensity was also higher in MeOH. This behavior is indicative of the dyes
aggregating in water and disaggregating in MeOH. Moreover it is possible that differences
in the polarity of the solvents could also affect the spectral features. The order of absorption
in MeOH was EtNBS > EtNBS-N > EtNBS-Sp > EtNBS-So > EtNBS-A > EtNBS-Ac >
EtNBS-G. The order of absorption in water was EtNBS > EtNBS-So > EtNBS-So > EtNBS-
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N > EtNBS-A > EtNBS-G > EtNBS-Ac. The differences between the orders of the
compounds in MeOH and in water are presumably due to differences in solubility between
the two solvents. The fluorescence emission spectra after excitation at the absorption
maximum of the seven compounds are shown in Figure 2A (MeOH) and Figure 2B (water).
The difference between the magnitude of the emission in MeOH and in water (MeOH >>>
H2O) was even more pronounced than it was for the difference seen in absorption. The
order of fluorescence intensity in MeOH was EtNBS > EtNBS-N > EtNBS-Sp ≈ EtNBS-G
> EtNBS-So > EtNBS-A. EtNBS-Ac had no detectable fluorescence emission at all. In
water the order of fluorescence emission was EtNBS > EtNBS-Sp > EtNBS-N > EtNBs-So
> EtNBS-G > EtNBS-Ac ≈ EtNBS-A.
ROS probe data
The ROS probe data for the seven compounds are shown in Fig 3A (SOSG) and Fig 3B
(HPF). For SOSG the order of effectiveness was as follows: EtNBS ≈ EtNBS-So ≈ EtNBS-
Sp > EtNBS-G > EtNBS-N > EtNBS-A > EtNBS-Ac (EtNBS-Ac had no more activation
than SOSG alone). For HPF the order of effectiveness was EtNBS > EtNBS-Sp > EtNBS-So
> EtNBS-G > EtNBS-N > EtNBS-A > EtNBS-Ac (again EtNBS-Ac had hardly more
activation than HPF alone).
Antimicrobial PDI
The aPDI data is shown in Figure 4 (EtNBS), Figure 5 (EtNBS-N), Figure 6 (EtNBS-A),
Figure 7 (EtNBS-Ac), Figure 8 (EtNBS-So), Figure 9 (EtNBS-Sp) and Figure 10 (EtNBS-
G). The parent EtNBS structure was most effective in mediating photokilling of all four
microbial cells (Figure 4) with > 6 logs (equivalent to eradication) being obtained with all
species. The order of susceptibility was S. aureus > E. faecalis > A. baumannii > E. coli.
Significant dark toxicity become evident at 50 uM concentration except in the case of S.
aureus. The 1-substituted nitro-compound (EtNBS-N, Figure 5) only provided good
photokilling (5-6 logs) for the two Gram-positive species with E. faecalis being somewhat
more susceptible than S. aureus. There was only low dark toxicity. The 1-substituted amino
compound (EtNBS-A, Figure 6) was only able to mediate PDI of S. aureus and then the
killing was less than 3 logs. The acetamido derivative (EtNBS-Ac, Figure 7) did not provide
any significant PDI effect, but did have dark toxicity against the Gram-negative species,
especially A. baumannii. The 1-substituted N-ethylpropylsulfonamido derivative (EtNBS-
So, Figure 8) gave significant killing of both Gram-positive species (4 logs for S. aureus and
greater than 5 logs for E. faecalis) but not Gram-negatives with low dark toxicity. The 4-
substituted N-ethylpropylsulfonamido derivative (EtNBS-Sp, Figure 9) gave more PDI of
Gram-positive species compared to ETNBS-So (> 5 logs of S. aureus and eradication of E.
faecalis). Again there was no killing of Gram-negatives and no dark toxicity. The
quaternized derivative (EtNBS-G, Figure 10) gave substantial killing (> 5 logs) of all four
species, with Gram-negatives being more susceptible (both E. coli and A.baumannii were
eradicated. Dark toxicity was low. Therefore the overall order of effectiveness taking into
account dark toxicity was EtNBS-G > EtNBS > EtNBS-Sp > EtNBS-N > EtNBS-So >
EtNBS-A > EtNBS-Ac.
Bacterial uptake data
In order to test to what extent the differences we observed in the PDT mediated bacterial
killing were due to differences in the affinity of the different dyes for the two kinds of
bacterial cells (Gram-positive and Gram-negative), we measured the uptake. Because the
fluorescence quantum yield of EtNBS-Ac was close to zero, we were not able to obtain
meaningful data for the bacterial binding of this compound. The binding for the remaining
six compounds is shown in Figures 11A-D. There were differences in the broad overall
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compound uptake between different bacterial species. A. baumannii (Figure 11D) was the
highest, followed by S. aureus (Figure 11A), then E. faecalis (Figure 11B) and E. coli
(Figure 11C) was the lowest. Although we do not have formal proof of this, we have
evidence that suggests that Acinetobacter baumannii does not have the same permeability
barrier shared by many other Gram-negative bacteria such as E. coli and P. aeruginosa. This
explains why several investigators have reported that A. baumannii is particularly
susceptible to PDT. The highest bacterial uptakes amongst the six compounds were seen
with EtNBS, EtNBS-N and EtNBS-G, which were also the three compounds which showed
the highest degree of photodynamic bacterial killing. Conversely the three compounds with
the lowest uptake were also the least active in photodynamic killing. It should be noted that
the uptake of EtNBS-Sp (more photodynamically active) was in every case higher than the
uptake of EtNBS-So (less photodynamically active). Although the uptake measurements did
parallel the order of photodynamic activity for E. faecalis, but not so much for other species,
we concluded that differences in uptake could not fully explain the large differences in
activity. The differences in activity can be explained by a complex combination of
differences in uptake and differences in photochemical activity as shown by absorption and
fluorescence spectroscopy and by ROS probe studies.
Discussion
Comparison of EtNBS and 1-substituted derivatives
The somewhat surprising reduction in absorption, fluorescence, ROS generating ability and
the PDT activity for the three 1-substituted derivatives of EtNBS compared to the parent
EtNBS compound led to the hypothesis that the substituent at the 1 position interfered with
the N-atom at the 12-position of the benzophenothiazinium ring system and distorted the
planar conjugated structure of the tricyclic ring system, thus impairing the photoactivity.
This hypothesis was bolstered by the observation that EtNBS-Ac with the bulkiest 1-
substituent, showed the largest drop in absorption of the four compounds compared, had no
detectable fluorescence and was completely unable to generate either 1O2 or HO• and could
not even kill any Gram-positive bacteria after illumination. However EtNBS-So has an even
bulkier group in the 1-position and showed considerably more activity than EtNBS-Ac, so
this explanation does not completely account for the observation. There was also an
interesting finding that an electron withdrawing substituent in the 1-position was more
effective than an electron donating substituent. The reasons for this difference can only be
speculated on but include the idea that electron transfer reactions from or to the excited state
of the benzophenothiazinium dye (Type I mechanism) could be influenced by the presence
of electron withdrawing substituents. There were also differences in bacterial uptake
observed by changing the 1-substituent. The unsubstituted EtNBS had high cell uptake but
so also did the electron-withdrawing EtNBS-N. The electron donating ETNBS-A had lower
uptake while the uptake of EtNBS-Ac could not be measured. The possibility that it was
overall lipophilicity rather than steric or electronic factors that primarily influenced the PDU
efficacy was tested by calculating log P and TPSA values (Table 1). The PDI efficacy
correlated well with descending logP value EtNBS > EtNBS-N > EtNBS-A > EtNBS-Ac,
but not with TPSA values EtNBS-N > EtNBS-A > EtNBS-A > EtNBS.
Comparison of 1 and 4-substituted sulfonamide derivatives
To test the hypothesis outlined above (distortion of the ring planarity by a 1-substituent) we
prepared two isomeric derivatives with the same bulky N-ethylpropylsulfonamido group
substituted either at the 1-position or at the 4-position of the benzene ring. The absorption of
the 4-isomer (EtNBS-Sp) was somewhat higher than that of the 1-isomer (EtNBS-So) both
in water and methanol. Furthermore the fluorescence of EtNBS-Sp was 2.5 times higher
than that of EtNBS-So in methanol (Fig 2A) and 14 times higher in water (Fig 2B).
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However the ROS generation showed that SOSG was activated to a similar degree by
EtNBS-Sp compared to EtNBS-So (Fig 3A), while HPF was activated about 25% more (Fig
3B). The photokilling of S .aureus was also higher for the 4-isomer than for the 1-isomer
(although not by a large amount). Taken together these data confirm the hypothesis that
reduction in the photoactivity of the benzophenothiazinium ring is partly due to 1-
substituents distorting the planar ring structure. However the bacterial uptake of the less
active EtNBS-So was consistently lower than the uptake of the more active EtNBS-Sp for
all species suggesting that bacterial binding is also important in determining the
effectiveness of PDI. It may be the case that the more planar structure of the unmodified
EtNBS favors bacterial binding, while the distorted ring structures of the derivatives do not
bind to the bacterial cell walls so effectively.
Comparison of EtNBS and arginine derivative
We decided to synthesize an arginine derivative of EtNBS based on the hypothesis that an
extra basic guanidine imino-group would impart enough additional cationic charge to
EtNBS to increase its activity against Gram-negative bacteria, where pronounced cationic
charge is known to be the most advantageous molecular feature [8]. The product EtNBS-G
had lower activity than the parent EtNBS against the Gram-positive S. aureus as expected
since it has been reported that a large number of cationic groups on an antimicrobial
photosensitizer are not beneficial for enhancing performance against Gram-positive bacteria
[26, 27]. However the PDI activity was enhanced against the Gram-negative species, and
especially the ratio between the light-mediated toxicity (PDI) and the dark toxicity was
improved in the case of EtNBS-G. This observation is presumably because the dark toxicity
of EtNBS is mediated by lipophilic disruption of bacterial membranes due to uptake of the
hydrophobic dye as has been shown for phenothiazinium analogues such as dimethyl
methylene blue [28, 29]. By contrast, the high activity of EtNBS-G is due to the
guanidinium charge mediating the displacement of divalent cations (Ca2+ and Mg2+) in the
LPS structure of the cell wall as reported for cationic phthalocyanines [30], and this type of
cell disruption does not cause marked dark toxicity, but does allow efficient PDI.
Conclusion
In retrospect, we might not have chosen to synthesize 1-substituted EtNBS derivatives had
we known the results of the study a priori. But although we did not succeed to prepare more
potent analogues of EtNBS as antimicrobial photosensitizers as we originally hoped, we did
discover some interesting new information about the effects that molecular geometry has on
the absorption spectra, fluorescence emission, photoproduction of ROS and antimicrobial
PDI capacity of these benzophenothiazinium dye derivatives. The large differences in PDI
activity amongst the seven dye molecular structures were found to be due to a complex
interrelationship between differences in photochemical generation of the ROS 1O2 and HO•
and differences in binding to the Gram-positive and Gram-negative bacterial cell walls. The
addition of a guanidine residue to an existing amino group may be a general way of
increasing the overall cationic charge on antimicrobial photosensitizer and increasing its
activity against Gram-negative bacteria. The data also suggest that compounds bearing two
(or even three cationic charges) may be the best candidates for maximizing the antimicrobial
PDI activity of this class of compounds.
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Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
CFU colony forming units
DMA N,N-dimethylacetamide
EtNBA 5-ethylamino-9-diethylaminobenzo[a]phenoxazinium chloride
EtNBS 5-ethylamino-9-diethylaminobenzo[a]phenthiazinium chloride
EtNBSe 5-ethylamino-9-diethylaminobenzo[a]phenoselenazinium chloride
EtNBS-N N-(9-(diethylamino)-1-nitro-5H-benzo[a]phenothiazin-5-
ylidene)ethanaminium chloride
EtNBS-A N-(1-amino-9-(diethylamino)-5H-benzo[a]phenothiazin-5-
ylidene)ethanaminium chloride
EtNBS-Ac N-(1-acetamido-9-(diethylamino)-5H-benzo[a]phenothiazin-5-ylidene)-
ethanaminium chloride
EtNBS-So N-(9-(diethylamino)-1-(N-ethylpropylsulfonamido)-5H-
benzo[a]phenothiazin-5-ylidene)ethanaminium chloride
EtNBS-Sp N-(9-(diethylamino)-4-(N-ethylpropylsulfonamido)-5H-
benzo[a]phenothiazin-5-ylidene)ethanaminium chloride
EtNBS-G 2-((amino(iminio)methyl)amino)-N-(9-(diethylamino)-5H-
benzo[a]phenothiazin-5-ylidene)ethanaminium chloride
HPF 3-(4-hydroxyphenyl)fluorescein
PBS phosphate buffered saline
PDT photodynamic therapy
PS photosensitizer
ROS reactive oxygen species
SAR structure activity relationship
SOSG singlet oxygen sensor green
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Highlights
Seven derivatives of Nile blue EtNBS have been synthesized and characterized
Absorption, fluorescence, light-mediated reactive oxygen species generation and
bacterial killing
1-substituents were less active than parent with electron withdrawing better than electron
donating
4-substituents were better than 1-substituents, and a guanidinium killed Gram-negatives
Effectiveness as antimicrobial photosensitzers is a mixture of bacterial uptake and
photochemistry
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Figure 1.
Absorption spectra of the seven EtNBS analogues (A) 10 μM in methanol and (B) 10 μM in
double distilled water.
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Figure 2.
Fluorescence emission spectra after excitation at the absorption maximum for each
compound of the seven EtNBS analogues (A) 1 μM in methanol and (B) 1 μM in double
distilled water.
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Figure 3.
Activation of fluorescent ROS probes (5 μM) in PBS with the seven EtNBS analogues (5
μM) exposed to increasing fluences of 635-nm light. (A) Singlet oxygen sensor green
(SOSG); (b) Hydroxyphenyl-fluorescein (HPF).
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Figure 4.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS
and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C) E.
coli; (D) A. baumannii.
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Figure 5.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-N
and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C) E.
coli; (D) A. baumannii.
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Figure 6.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-A
and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C) E.
coli; (D) A. baumannii.
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Figure 7.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-
Ac and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C)
E. coli; (D) A. baumannii.
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Figure 8.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-
So and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C)
E. coli; (D) A. baumannii.
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Figure 9.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-
Sp and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C)
E. coli; (D) A. baumannii.
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Figure 10.
Antimicrobial PDI of the four bacteria incubated with increasing concentrations of EtNBS-G
and exposed after 10 min to 10 J/cm2 of 635-nm light. (A) S. aureus; (B) E. faecalis; (C) E.
coli; (D) A. baumannii.
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Figure 11.
Uptake (calculated via fluorescence calibration curves and protein determination) of the six
EtNBS analogues (EtNBS-Ac had too low fluorescence to be measured) by the four bacteria
after 10 min incubation. (A) S. aureus; (B) E. faecalis; (C) E. coli; (D) A. baumannii.
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Table 1
Structures of the seven benzophenothiazinium dyes, LogP and TPSA values.
Compound Structure Calc Log Pa Meas Log Pb TPSAc
EtNBS 1.74 2.87±0.19 29.57
EtNBS-N 1.503 2.03±0.27 81.38
EtNBS-A 0.76 1.77±0.42 55.59
EtNBS-Ac 0.98 1.36±0.2 58.67
EtNBS-So 2.35 2.19±0.16 66.95
EtNBS-Sp 2.35 2.45±012 66.95
EtNBS-G 0.25 0.49±0.26 93.21
a
Log(10) of octanol:water partition coefficient calculated by ChemBioDraw.
b
Measured Log P values determined experimentally
c
Topological polar surface area calculated by ChemBioDraw.
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